Immunological findings in MIC patients
Based on preclinical data and the one- and three-year results of this phase I study (
Immunological results of MIC patients. Percentage of CD4A second regulatory B lymphocyte subset, CD19Except for HLA antibody monitoring (see above), no immunological analyses were available for transplanted controls.